Compare IMUX & RFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMUX | RFAM |
|---|---|---|
| Founded | 2016 | 2025 |
| Country | United States | Singapore |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.6M | 138.5M |
| IPO Year | 2013 | 2026 |
| Metric | IMUX | RFAM |
|---|---|---|
| Price | $1.18 | $9.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.80 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 24.5K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $9.77 |
| 52 Week High | $1.51 | $9.94 |
| Indicator | IMUX | RFAM |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 48.39 |
| Support Level | $1.05 | $9.77 |
| Resistance Level | $1.35 | N/A |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 53.13 | 41.00 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.